Abstract LB237: p300-selective degraders illustrate potent anti-tumor activity in a distinct subset of cancers

Authors: Mike R. Russell, Harshil Dhruv, Xuqing Zhang, Jeremy Roach, Nathan Kendsersky, Nelisa Bechtel, Kelsey Annen, Brian Vidal, Matt Tudor, Qiaolin Deng, Clemente Aguilar-Bonavides, Elham Behshad, Sudeep Banjade, Corey Strickland, Larry Jolivette, Helai Mohammad

Published: 2025-04-25

DOI: 10.1158/1538-7445.am2025-lb237

Source: Full article